Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sofosbuvir. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced patent CN104151352A details high-purity Sofosbuvir intermediate preparation via dynamic kinetic resolution ensuring supply chain reliability and cost efficiency.
Patent CN111018844B reveals a novel 3-step synthesis of sofosbuvir key intermediates from uridine, offering significant cost reduction and improved chiral purity for API manufacturing.
Patent CN107245064B details a safer synthesis route for Sofosbuvir intermediates offering high yield and supply chain stability for pharmaceutical manufacturing.
Patent CN106188193A reveals a novel N-protection strategy for Sofosbuvir intermediates, ensuring high purity, reduced impurities, and scalable manufacturing for global supply chains.
Patent CN107245064A details safer borohydride reduction for Sofosbuvir intermediates. Achieve high purity and cost reduction in API manufacturing with scalable recovery methods.
Patent CN111848554B details a high-purity synthesis route for sofosbuvir intermediate impurity KD003, offering enhanced supply chain reliability and cost-effective manufacturing solutions.
Advanced synthetic route for Sofosbuvir impurities using orthogonal protection strategies. Ensures high purity reference standards for pharmaceutical quality control and regulatory compliance.
Patent CN106565805B reveals a cost-effective D-ribose route for Sofosbuvir, offering reliable supply chain solutions and reduced manufacturing complexity for global pharmaceutical buyers.
Patent CN107646037A reveals a novel succinimide-based route for Sofosbuvir intermediates, offering improved selectivity and supply chain stability for pharmaceutical manufacturers.
Advanced stereoselective preparation of Sofosbuvir intermediates via patent CN105153257B. Reduces production costs and enhances supply chain reliability for global pharmaceutical manufacturers.